TScan Therapeutics, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
830 WINTER STREET, WALTHAM, MA, 02451
Mailing Address
830 WINTER STREET, WALTHAM, MA, 02451
Phone
857-399-9500
Fiscal Year End
1231
EIN
825282075
Financial Overview
FY2025
$-1.00
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 2, 2026 | View on SEC |
| 10-K Annual financial report | March 4, 2026 | View on SEC |
| 8-K Current report of material events | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | January 22, 2026 | View on SEC |
| 4 Insider stock transaction report | January 22, 2026 | View on SEC |
| 4 Insider stock transaction report | January 22, 2026 | View on SEC |
| 4 Insider stock transaction report | January 22, 2026 | View on SEC |
| 4 Insider stock transaction report | January 22, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 4 Insider stock transaction report | December 23, 2025 | View on SEC |
Annual Reports
10-K
March 4, 2026
- Strong collaboration revenue growth of over 260% to $10.3 million in 2025, primarily driven by the Amgen partnership.
- Lead blood cancer programs, TSC-100 and TSC-101, are advancing through Phase 1 clinical trials with strategic prioritization in late 2025.
Insider Trading
BUY
1 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Vaxcyte, Inc.
PCVX
Biological Products, (No Diagnostic Substances)
RECURSION PHARMACEUTICALS, INC.
RXRX
Biological Products, (No Diagnostic Substances)
MeiraGTx Holdings plc
MGTX
Biological Products, (No Diagnostic Substances)
Ginkgo Bioworks Holdings, Inc.
DNA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.